The technology developed by lncTAC Bio combines lncRNA with the most popular targeting chimera technology, which not only enhances the company's technology platform but also enables us to provide new innovative solutions for unmet clinical needs. Moreover, with the research and development of the UNAST^® platform, we provide a solution for the nucleic acid drug instability and delivery difficulties.